MSK is now offering COVID-19 vaccine to patients age 65 and over who live in New York State and are in active treatment with MSK on or after 1/1/20. Supply is limited. Please do not call your doctor about getting vaccinated. We will contact you directly. Read more
Developing New Treatments for T Cell Lymphoma
Share
Print
VIDEO | 05:00
Medical oncologist Steven M. Horwitz discusses the development and impact of three new, widely used therapies for T cell lymphoma: pralatrexate, romidepsin, and brentuximab vedotin.